Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Evotec SE
  6. Company
    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, womenÔÇÖs health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Number of employees : 3 572 people.
Sales per Business
20192020Delta
EVT Execute337.6175.6%373.3774.5% +10.59%
EVT Innovate94.3321.1%105.7221.1% +12.08%
Reconciling Items14.503.2%21.844.4% +50.56%
EUR in Million
Sales per region
20192020Delta
United States195.0443.7%247.8549.5% +27.07%
United Kingdom77.9017.4%93.9918.8% +20.65%
Rest of the World82.6818.5%77.7115.5% -6.01%
Germany27.986.3%44.328.8% +58.38%
France62.8314.1%37.067.4% -41.02%
EUR in Million
Managers
Name Title Age Since
Werner Lanthaler Chief Executive Officer 52 2009
Enno Spillner Chief Financial Officer 50 2016
Cord Dohrmann Chief Scientific Officer 57 2010
Craig Johnstone Chief Operating Officer 51 2012
Iris L÷w-Friedrich Chairman-Supervisory Board 61 2021
Volker Braun SVP, Head-Investor Relations & ESG - -
Gabriele Hansen Senior VP-Marketing & Global Communications - -
Members of the board
Name Title Age Since
Iris L÷w-Friedrich Chairman-Supervisory Board 61 2021
Elaine Sullivan, Dr. Member-Supervisory Board 60 2015
Mario Eugenio Cosimino Polywka, Dr. Member-Supervisory Board 58 2019
Roland Sackers Vice Chairman-Supervisory Board 52 2021
Kasim Kutay Member-Supervisory Board 56 -
Constanze Ulmer-Eilfort, Dr. Member-Supervisory Board 59 2021
Shareholders
NameEquities%
Novo Holdings A/S (Investment Company) 18,100,786 10.3%
Mubadala Investment Co. PJSC (Investment Management) 11,481,502 6.55%
Roland Oetker 8,345,000 4.76%
T. Rowe Price Associates, Inc. (Investment Management) 5,290,844 3.02%
Allianz Global Investors GmbH 5,256,528 3.00%
Impax Asset Management Ltd. 4,933,816 2.81%
DWS Investment GmbH 4,805,320 2.74%
The Vanguard Group, Inc. 4,106,924 2.34%
T. Rowe Price International Ltd. 3,773,600 2.15%
Liontrust Investments Ltd. 3,464,500 1.98%
Company contact information
Evotec SE
Manfred Eigen Campus
Essener Bogen 7
Hamburg 22419

Phone : +49.40.56081.0
Fax : +49.40.56081.222
Web : http://evotec.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Evotec SE
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
EVOTEC SE-17.11%7 049
MODERNA, INC.-19.39%83 008
LONZA GROUP AG-15.15%52 584
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684
CELLTRION, INC.-13.64%20 026
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.-5.78%17 915
ALNYLAM PHARMACEUTICALS, INC.-12.43%17 761
PPD, INC.38.16%16 614
INCYTE CORPORATION2.02%16 540
PHARMARON BEIJING CO., LTD.-5.78%15 897
HANGZHOU TIGERMED CONSULTING CO., LTD-3.51%15 828
BIO-TECHNE CORPORATION-24.59%15 329
QIAGEN N.V.-12.77%11 006
PRA HEALTH SCIENCES, INC.0.00%10 965
UNITED THERAPEUTICS CORPORATION-0.98%9 636
SYNEOS HEALTH, INC.-12.36%9 331
BACHEM HOLDING AG-23.32%8 869
GENSCRIPT BIOTECH CORPORATION-7.25%8 638
NOVAVAX, INC.-22.54%8 379